SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Board changes

19 May 2026 07:00

RNS Number : 7981E
Caledonia Investments PLC
19 May 2026
 

 

Caledonia Investments plc

 

Board changes

 

Caledonia Investments plc ("Caledonia" or the "Company") announces that the board has appointed Will Wyatt as David Stewart's successor as Company Chair. David will retire from the board at the Company's forthcoming annual general meeting (the "AGM"). In addition, The Hon Charles Cayzer has decided not to stand for re-election as a non-executive director at the AGM.

 

Will successfully led Caledonia as Chief Executive for over a decade until becoming a non-executive director in July 2022. He is a member of the Cayzer family and has a deep understanding of Caledonia's culture, investment strategy and long-term approach.

 

Will's appointment as David's successor follows the completion of a formal, rigorous and transparent process undertaken by the Company's Nomination Committee led by Guy Davison, Senior Independent Director. Major shareholders, who were consulted in advance, confirmed their broad support for Will's appointment.

 

David Stewart, Caledonia's Chair, commenting on these changes, said:

 

"I am very pleased to announce Will as my successor. He has a unique perspective and long-standing knowledge of the business, which I am sure will serve the Company well as he takes on this new role. I wish him every success.

 

Charles has been ever-present on the board of Caledonia since 1985, two years before Caledonia disposed of its stake in British & Commonwealth Holdings Plc. He has helped guide the strategy and has played a key part creating Caledonia's unique culture both as an executive and latterly, as a non-executive director. We shall miss his wisdom and extensive experience and wish him a long and happy retirement after four decades of service.

 

On a personal note, it has been an absolute privilege to serve as Chair, and as I step down at this year's AGM, I do so with confidence in Caledonia's future."

 

Will Wyatt, non-executive director and Chair elect, commented:

 

"It is an honour to be appointed as Chair, and I look forward to continuing to work with the board and management team in this new capacity.

 

On behalf of the board, I would like to thank David for his 11 years as a director, nine years of which were as Chair. During this time he led the board through many major events including Brexit, the Covid-19 pandemic and the ensuing turbulence in financial markets. His leadership and contribution have helped ensure that Caledonia remains well positioned to execute its long-term strategy."

 

19 May 2026

 

Enquiries

 

Company contacts

Caledonia Investments plc

+44 20 7802 8080

investorrelations@caledonia.com

 

David Stewart

Chair

 

Guy Davison

Senior Independent Director

 

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

caledonia@teneo.com

 

Caledonia Investments plc

 

Caledonia is a FTSE 250 self-managed investment trust company with a long track record of delivering consistent returns and progressive annual dividend payments to shareholders.

 

Our aim is to generate long-term compounding real returns that outperform inflation by 3% to 6% over the medium to long term, and the FTSE All-Share index over 10 years.

 

We are a long-term investor and hold investments in both listed and private markets across three pools: Public Companies, Private Capital and Funds. Each has a strategic allocation of capital, investment strategy and target return. The result is a well-balanced diversified portfolio of investments with a global reach.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFUFMAEMSEII
Date   Source Headline
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 202411:29 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.